BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
11.39
-0.85 (-6.94%)
At close: Dec 5, 2025, 4:00 PM EST
11.83
+0.44 (3.85%)
After-hours: Dec 5, 2025, 7:03 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $21.47 million as of December 5, 2025. Its market cap has decreased by -0.13% in one year.
Market Cap
21.47M
Enterprise Value
3.09M
1-Year Change
-0.13%
Ranking
Category
Stock Price
$11.39
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $21.47M, a decrease of -17.42%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 23.10M | -7.60% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |